oxonic acid has been researched along with Cancer of Ovary in 22 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes." | 5.40 | Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014) |
| "Ovarian cancer was suspected, and total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy were performed." | 1.56 | A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy. ( Aida, T; Baba, T; Saito, T; Sasou, S; Shoji, T; Takeshita, R, 2020) |
| "There was no recurrence for more than 2 years after the lung surgery." | 1.46 | [A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period]. ( Ikeda, H; Kakegawa, S; Matsumoto, I; Saito, D; Takata, M; Takemura, H; Tamura, M; Tanaka, Y; Yoshida, S, 2017) |
| "Ovarian metastasis from the gastric cancer was diagnosed, and the response to 3 courses of weekly PTX was stable disease." | 1.42 | [A Case of Long-Term Survival after Surgeries for Gastric Cancer and Metachronous Ovarian Metastasis]. ( Akasaka, H; Hakamada, K; Kubo, N; Muroya, T; Okano, K; Sakuraba, S; Uchida, C; Wajima, N; Yoshida, T, 2015) |
| "Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes." | 1.40 | Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014) |
| "Stage IV gastric cancer has poor prognosis, and median survival time (MST) is reported to range from 6 to 13 months." | 1.40 | [A case of Stage IV gastric cancer was successfully treated with multi combination chemotherapy with S-1]. ( Akita, H; Amagasa, H; Ami, K; Ando, M; Arai, K; Fujiya, K; Fukuda, A; Ganno, H; Gokita, K; Imai, K; Kawai, Y; Kodaka, F; Matsunaga, Y; Nagahama, T; Ohshima, N; Okada, Y; Takagi, M; Tei, S; Yamada, Y, 2014) |
| "However, the Krukenberg tumor rapidly increased in size after 4 years and she complained of abdominal distension." | 1.40 | Giant Krukenberg tumor from a perforated gastric cancer that was successfully removed after multidisciplinary therapy: report of a case. ( Harada, T; Isogai, M; Kamei, K; Kaneoka, Y; Maeda, A; Sunagawa, M; Takayama, Y, 2014) |
| "A 35-year-old female with scirrhous stomach cancer (stage IV) was treated with a combination of 5-aminolevulinic acid (ALA), sodium dichloroacetate (DCA), hyperthermotherapy, and immunotherapy as terminal care." | 1.39 | A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA). ( Goto, S; Kamigaki, T; Saito, M; Yano, K, 2013) |
| "In ovary metastasis of gastric cancer, even if accompanied by peritoneum metastasis, ovarian resection as a reduction surgery followed by chemotherapy may improve survival." | 1.36 | [A case of gastric cancer with bilateral ovarian metastasis after gastrectomy performed ovarian resection]. ( Fukunaga, M; Furukawa, H; Imamura, H; Kawabata, R; Kishimoto, T; Miwa, H; Miyanishi, K; Ohzato, H; Yamamoto, T, 2010) |
| "Chemotherapies for recurrent gastric cancer have not yet been established." | 1.33 | [A case of advanced gastric cancer with lymphangitis carcinomatosa after operation of Krukenberg tumor treated by TS-1 plus CPT-11 as third-line chemotherapy]. ( Akiba, Y; Hibi, T; Higuchi, H; Iizuka, H; Izumiya, M; Nagata, H; Takaishi, H; Yamagishi, Y, 2005) |
| "Survival of patients with advanced gastric cancer with Krukenberg's tumor is poor." | 1.32 | [A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum]. ( Akiba, Y; Aoki, D; Hibi, T; Ishii, H; Kato, S; Mukai, M; Naito, K; Takada, Y; Watanabe, C, 2003) |
| "A patient with recurrent gastric cancer which infiltrated the pelvic muscle after the treatment of paraaortic lymph node and ovarian metastases was successfully managed by a novel oral anticancer drug, TS-1." | 1.31 | [A case of recurrent gastric cancer successfully treated with TS-1]. ( Higaki, K; Ikeda, T; Kobayashi, N; Ninomiya, M; Ohno, S; Okamura, S; Onoda, T; Shiozaki, S; Takakura, N, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Shoji, T | 1 |
| Takeshita, R | 1 |
| Saito, T | 1 |
| Aida, T | 1 |
| Sasou, S | 1 |
| Baba, T | 1 |
| Naruse, T | 1 |
| Hirono, Y | 1 |
| Kurebayashi, H | 1 |
| Katayama, H | 1 |
| Sawai, K | 1 |
| Morikawa, M | 1 |
| Koneri, K | 1 |
| Tamaki, M | 1 |
| Murakami, M | 1 |
| Goi, T | 1 |
| Yamada, M | 1 |
| Nakai, K | 1 |
| Inoue, K | 1 |
| Hijikawa, T | 1 |
| Hachimine, T | 1 |
| Yasuda, K | 1 |
| Uemura, Y | 1 |
| Yoshioka, K | 1 |
| Kon, M | 1 |
| Saito, M | 1 |
| Yano, K | 2 |
| Kamigaki, T | 1 |
| Goto, S | 1 |
| Kitayama, J | 1 |
| Ishigami, H | 1 |
| Yamaguchi, H | 1 |
| Yamashita, H | 1 |
| Emoto, S | 1 |
| Kaisaki, S | 1 |
| Watanabe, T | 1 |
| Matsuoka, T | 1 |
| Hosaka, S | 1 |
| Inada, K | 1 |
| Kawamoto, S | 1 |
| Yang, X | 1 |
| Xiang, X | 1 |
| Xia, M | 1 |
| Su, J | 1 |
| Wu, Y | 1 |
| Shen, L | 1 |
| Xu, Y | 1 |
| Sun, L | 1 |
| Ami, K | 1 |
| Gokita, K | 1 |
| Kawai, Y | 1 |
| Matsunaga, Y | 1 |
| Fujiya, K | 1 |
| Ohshima, N | 1 |
| Amagasa, H | 1 |
| Ganno, H | 1 |
| Imai, K | 1 |
| Fukuda, A | 1 |
| Nagahama, T | 1 |
| Ando, M | 1 |
| Okada, Y | 1 |
| Akita, H | 1 |
| Tei, S | 1 |
| Yamada, Y | 1 |
| Takagi, M | 1 |
| Kodaka, F | 1 |
| Arai, K | 1 |
| Yoshida, T | 1 |
| Wajima, N | 1 |
| Akasaka, H | 1 |
| Sakuraba, S | 1 |
| Muroya, T | 1 |
| Kubo, N | 1 |
| Okano, K | 1 |
| Uchida, C | 1 |
| Hakamada, K | 1 |
| Takata, M | 1 |
| Matsumoto, I | 1 |
| Tanaka, Y | 1 |
| Saito, D | 1 |
| Yoshida, S | 1 |
| Kakegawa, S | 1 |
| Tamura, M | 1 |
| Takemura, H | 1 |
| Ikeda, H | 1 |
| Sasaki, H | 1 |
| Idani, F | 1 |
| Asami, S | 1 |
| Komoto, S | 1 |
| Kubota, T | 1 |
| Kumano, K | 1 |
| Kurose, Y | 1 |
| Kubo, S | 1 |
| Nojima, H | 1 |
| Yoshioka, T | 1 |
| Muro, M | 1 |
| Kin, H | 1 |
| Takakura, N | 2 |
| Imamura, H | 1 |
| Kishimoto, T | 1 |
| Kawabata, R | 1 |
| Furukawa, H | 1 |
| Fukunaga, M | 1 |
| Ohzato, H | 1 |
| Miyanishi, K | 1 |
| Yamamoto, T | 1 |
| Miwa, H | 1 |
| Ebisui, C | 1 |
| Ohkubo, K | 1 |
| Akitake, H | 1 |
| Ohtsuka, M | 1 |
| Maekawa, T | 2 |
| Yoshioka, S | 2 |
| Hama, N | 2 |
| Kashiwazaki, M | 2 |
| Taniguchi, M | 2 |
| Tsujie, M | 2 |
| Konishi, M | 2 |
| Fujimoto, T | 2 |
| Okubo, K | 1 |
| Asukai, K | 1 |
| Hata, T | 1 |
| Nakanishi, M | 1 |
| Suganuma, Y | 1 |
| Nagashima, T | 1 |
| Fujimura, M | 1 |
| Kou, K | 1 |
| Shibuya, M | 1 |
| Sunagawa, M | 1 |
| Isogai, M | 1 |
| Harada, T | 1 |
| Kaneoka, Y | 1 |
| Kamei, K | 1 |
| Maeda, A | 1 |
| Takayama, Y | 1 |
| Akiba, Y | 2 |
| Watanabe, C | 1 |
| Takada, Y | 1 |
| Naito, K | 1 |
| Aoki, D | 1 |
| Mukai, M | 1 |
| Kato, S | 1 |
| Hibi, T | 2 |
| Ishii, H | 1 |
| Yamagishi, Y | 1 |
| Izumiya, M | 1 |
| Higuchi, H | 1 |
| Iizuka, H | 1 |
| Takaishi, H | 1 |
| Nagata, H | 1 |
| Kodama, T | 1 |
| Ishida, H | 1 |
| Okino, T | 1 |
| Okamoto, R | 1 |
| Takahashi, H | 1 |
| Hayashi, N | 1 |
| Mori, K | 1 |
| Noguchi, M | 1 |
| Toshimitsu, H | 1 |
| Matoba, K | 1 |
| Ozasa, H | 1 |
| Shimizu, R | 1 |
| Inagaki, D | 1 |
| Katayama, K | 1 |
| Shiraishi, R | 1 |
| Tanabe, H | 1 |
| Tani, K | 1 |
| Oosawa, H | 1 |
| Wada, H | 1 |
| Yasuda, S | 1 |
| Onoda, T | 1 |
| Okamura, S | 1 |
| Shiozaki, S | 1 |
| Ohno, S | 1 |
| Higaki, K | 1 |
| Ninomiya, M | 1 |
| Ikeda, T | 1 |
| Kobayashi, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Docetaxel, Oxaliplatin, Fluorouracil (FLOT Regimen) Combined With Teriprizumab (PD-1) in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis: an Open, One-arm, Exploratory Study[NCT04886193] | 20 participants (Anticipated) | Interventional | 2021-04-16 | Recruiting | |||
| The Exploratory Study of Conversion Surgery for Apatinib in Combination With Oxaliplatin/S-1(SOX) for Patients With Unresectable Gastric Cancer[NCT03007446] | Phase 2 | 20 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
22 other studies available for oxonic acid and Cancer of Ovary
| Article | Year |
|---|---|
A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy.
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Carcinoma, Signet Ring Cell; Drug Combin | 2020 |
[A Long Term Survival Case of Gastric Cancer with Peritoneal Dissemination Responding to Intraperitoneal Chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Human | 2020 |
[A Case Report of Long-Term Survival after SOX Chemotherapy for Metastatic Ovarian Tumor of Gastric Cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Hysterectomy; Kru | 2017 |
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocol | 2013 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
[A case of delayed subcutaneous metastases of gastric carcinoma effectively treated with S-1 plus cisplatin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combina | 2013 |
Inhibition of JNK3 promotes apoptosis induced by BH3 mimetic S1 in chemoresistant human ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Biomimetic Materials | 2015 |
[A case of Stage IV gastric cancer was successfully treated with multi combination chemotherapy with S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans | 2014 |
[A Case of Long-Term Survival after Surgeries for Gastric Cancer and Metachronous Ovarian Metastasis].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug C | 2015 |
[A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Middle Aged; Ova | 2017 |
[A long-term survival case of bilateral ovarian metastasis of progressive gastric cancer treated by chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplas | 2010 |
[A case of gastric cancer with bilateral ovarian metastasis after gastrectomy performed ovarian resection].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2010 |
[A case of ovarian metastasis from colon cancer successfully treated with multidisciplinary therapy].
Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2010 |
[A case report of primary adenocarcinoma of small intestine].
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2010 |
[A case of advanced mullerian cancer successfully treated with S-1 chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Combinations; Female; Humans; O | 2011 |
Giant Krukenberg tumor from a perforated gastric cancer that was successfully removed after multidisciplinary therapy: report of a case.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Mod | 2014 |
[A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; | 2003 |
[A case of advanced gastric cancer with lymphangitis carcinomatosa after operation of Krukenberg tumor treated by TS-1 plus CPT-11 as third-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2005 |
[A case report of complete response by TS-1 and paclitaxel combination chemotherapy for advanced gastric cancer].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administ | 2006 |
[A resected case of effective treatment with TS-1 and CDDP for advanced gastric cancer with carcinomatous ascites].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cholecystectomy; Cisplatin; Combined | 2006 |
[Multiple hepatic metastases and ovarian metastases of colon cancer responding to combined therapy with S-1 and CPT-11--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinations; | 2008 |
[A case of recurrent gastric cancer successfully treated with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Female; Huma | 2001 |